Merger with Glycosan BioSystems, Inc (Tables) (Merger with Glycosan BioSystems, Inc. [Member])

12 Months Ended

Dec. 31, 2013

Merger with Glycosan BioSystems, Inc. [Member]

Business Acquisition [Line Items]

Allocation of purchase price of merger

The total purchase price for the merger of $3,554,879 is being allocated as indicated:

Components of the purchase price:
BioTime common shares	$	2,600,000
BioTime warrants		954,879
Total purchase price	$	3,554,879
Allocation of purchase price:
Assets acquired and liabilities assumed:
Cash	$	5,908
Other current assets		64,520
Property, plant and equipment, net		81,183
Intangible assets		3,592,039
Current liabilities		(188,771	)
Net assets acquired	$	3,554,879